|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/66 | |
| A61K 31/325 | |||
| A61K 31/165 | |||
| A61K 47/10 | |||
| A61K 9/00 |
| (11) | Patento numeris | 1773353 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05773490.7 |
| Europos patento paraiškos padavimo data | 2005-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-02-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/025224 |
| Data | 2005-07-15 |
| (87) | Numeris | WO 2006/010152 |
| Data | 2006-01-26 |
| (30) | Numeris | Data | Šalis |
| 589075 P | 2004-07-19 | US |
| (72) |
BELL, Staneley, C., US
WONG, Albert, US
MANIAR, Manoj, US
|
| (73) |
Onconova Therapeutics, Inc.,
375 Pheasant Run, Newtown, PA 18940,
US
|
| (54) | FORMULATIONS FOR PARENTERAL ADMINISTRATION OF (E)-2,6-DIALKOXYSTRYRYL 4-SUBSTITUTED BENZYLSULFONES |
| FORMULATIONS FOR PARENTERAL ADMINISTRATION OF (E)-2,6-DIALKOXYSTRYRYL 4-SUBSTITUTED BENZYLSULFONES |